Publication | Closed Access

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

Hematological MalignancyPolymerase Chain ReactionPrognostic BiomarkersMolecular Diagnostic TechniquesResidual Disease DetectionMedicinePathologyCancer GenomicsMolecular DiagnosticsCandidate Control GenesOncologyRadiation OncologyCancer ResearchCancer Program